Thermo Fisher Scientific Dupilumab Monoclonal Antibody (6C9)

Applications

ELISA

• Tested Dilution: 0.001–0.05 µg/mL
• Recommended Competitive ELISA Dilution: 5–30 µg/mL

Product Specifications

Product Specific Information

• Reconstitute lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.
• Lyophilized product stable up to 1 year at -20°C from date of receipt.
• Upon reconstitution, store 2–3 weeks at 2–8°C or up to 12 months at -20°C or below.
• Avoid repeated freezing and thawing cycles.

Target Information

Dupilumab (trade name Dupixent) is an FDA-approved human monoclonal antibody for moderate-to-severe atopic dermatitis in patients aged 6 years and older.
Dupilumab binds to the interleukin-4 receptor alpha (IL-4Rα) subunit shared by IL-4 and IL-13 receptor complexes, inhibiting IL-4 and IL-13 signaling.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.